Results 281 to 290 of about 2,512,088 (315)

Estrogen Receptor (ER) and Progesterone Receptor (PgR) Expression in Endometrial Cancer-An Immunohistochemical Assessment. [PDF]

Diagnostics (Basel)
Przewoźny S, Rogaliński J, de Mezer M, Markowska A, Markowska J, Żurawski J.   +5 more
europepmc   +1 more source

Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components. [PDF]

Front Oncol
Schandiz H, Farkas L, Park D, Liu Y, Andersen SN, Geisler J, Sauer T.   +6 more
europepmc   +1 more source

Retraction: Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism. [PDF]

Biosci Rep
europepmc   +1 more source

Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.

Endocrinology
Diep CH, Spartz A, Truong TH, Dwyer AR, El-Ashry D, Lange CA.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly